Cancer Immunology – Products

Phylloceuticals has produced its first plant-based PD-1 inhibitor monoclonal antibody only 12 weeks after launching operations in Rapid City, SD.

Xcell Biosciences collaborates with Thermo Fisher to advance Treg and TIL therapies for autoimmune and solid tumor diseases.

Waters Corporation has acquired Halo Labs, a specialist in imaging technologies for detecting and analyzing particles in therapeutic products, including cell, protein, and gene therapies.

Terumo BCT and KBIOHealth have signed an MOU to develop workforce training for cell and gene therapy manufacturing in Korea. The program will focus on CAR-T and MSC therapy production using automated systems like Quantum Flex.

This application note introduces cytokines and their role in immunotherapy, outlines the key strategies employed in the development of next-generation cytokines, and presents the challenges and future directions

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative anticancer virus platform, the SJ-600 series.

We offer a comprehensive suite of immune checkpoint-related products, including high-quality proteins, inhibitor screening kits, stable cell lines, and PK assay kits for quantitative analysis.

This application focus explores how high-plex spatial profiling can be applied to better understand the role of T cells in cancer immune surveillance and how cancers evade the immune system.

This whitepaper discusses the classification of bsAbs targeting immunomodulatory checkpoints and highlights their applications in cancer immunotherapy.

Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.